Miami conference, shares details of newly confirmed attendees and fireside conversations you can’t miss


NEW YORK, November 6, 2021 (GLOBE NEWSWIRE) – via PsychedlicNewsWire – Psychedelic insights in microdose, a leading media company focused on promoting compelling content, financial analysis and events designed to bring the psychedelics industry to the forefront of modern medicine, will host the upcoming Wonderland Miami conference at the Adrienne Miami Arsht Center for the Performing Arts on November 8. -9, 2021. The event will provide attendees with information on some of the best companies, the latest IPOs, the latest opportunities and the most recent developments within the space.

Microdose Psychedelic Insights recently revealed more details on the event schedule. Speakers will include Robin Carhart-Harris, Distinguished Ralph Metzner Professor of Neurology and Psychiatry at the University of California, San Francisco; Professor David Nutt and Dr Ben Sessa of Awakn Life Sciences; Dr Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at John Hopkins; and Rick Doblin, Ph.D.

Roger McIntyre, MD, FRCPC CEO and Director, Braxia Scientific (CNSX: BRAX); Lamar Odom, former professional American basketball player; and Zappy Zapolin, Psychedelic Concierge are about to engage in an in-depth discussion about ketamine: past, present and future. Plus, a fireside chat moderated by Jemie Sae Koo will reunite Jason Silva and Matt Zemon from Psychable. They will develop the topic of accessibility as a key to unlocking the transformational power of psychedelic medicine for society as a whole.

Among the agenda items for the conference, Daniel Carcillo, a former Canadian professional ice hockey left winger, will sit for a fireside chat with one of the greatest heavyweight boxers of all time. time, Mike Tyson, to discuss their psychedelic space trips.

A list of the newly announced Fireside Sessions to be held at the conference include:

  • Welcome Renaissance: By stepping out of the fringes of the research world and shedding years of baggage from illicit recreational circles, scientists are making surprising strides in legitimizing the medical potential of psychedelics.

  • The road to federal acceptance: Where are we now? Where are we going?

  • Live Psychedelic Capital: Entrepreneurs will have the opportunity to present six venture capitalists and investors to a live audience.

  • Next Generation Psychedelics: Let’s talk about advances in R&D, trial designs, new compounds, regulatory affairs, patient engagement and new forms of partnerships.

  • Microdosing: fact or fiction? : Does microdosing improve focus, creativity and productivity? Are the touted effects real or fictitious?

  • Patent wars: Is corporate dominance over industry a significant threat or an opportunity to reduce stigma and integrate psychedelic medicine into mainstream healthcare?

  • Finance and psychedelics: Can consciousness and capitalism coexist?

  • Investing the shamanic way: Shamanic protocol for making investment decisions.

  • Psychedelics and technology: What role should technology play in the safe and effective delivery of psychedelic medicine?

  • Psychedelics & Sports

  • The specter of psychedelics: Respond to the need for psychedelic equity, access and affordability.

  • Psychedelics and new paradigms: Can psychedelic-assisted psychotherapy create a truly revolutionary paradigm shift in psychiatry?

  • Psychedelics and the current medical model

  • The last mile: A closer look at clinics and retreats: how does the model work and why is it needed?

With an unmissable collection of fireside talks and talks alongside some of the industry’s most illustrious speakers and thought leaders, the Wonderland: Miami conference has firmly anchored its position as the premier destination for the psychedelic industry. In addition to being a thought leadership platform, the conference also offers attendees the opportunity to connect with influential leaders in science, policy and business.

Additional information on the Wonderland Miami conference, as well as registration details, can be found on the conference website at

About Microdose Psychedelic Insights:
Psychedelic insights in microdose is your guide to the psychedelic medicine industry. With a vision to change the perception of the world of psychedelic medicine, we distribute and create the most compelling content, financial analysis, engaging events and groundbreaking education to drive the psychedelic industry to the forefront of modern medicine.

Psychedelic insights in microdose
[email protected]

Media contact:
IBN (InvestorBrand Network)
Los Angeles, California
310.299.1717 Office
[email protected]

Leave A Reply

Your email address will not be published.